Researchers have developed engineered stem cells that can deliver anti-inflammatory drugs at specific times by aligning with the body's natural circadian rhythms.

This innovative "chronogenetics" approach aims to improve the treatment of rheumatoid and juvenile arthritis by synchronising medication release with peak symptom times. The technology holds potential for personalised medicine across various conditions by optimising drug efficacy and reducing side effects.

Furthermore, this method could decrease the frequency of medication and potentially lower healthcare costs through better disease management. However, the ability to program cells also raises ethical considerations, alongside possibilities for integration with wearable technology for real-time treatment adjustments.

Original Article

Text Version

This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit airoad.substack.com